Oligonucleotide Therapeutics Society

Time matters! – Why PK/PD is important for oligo development

June 5th, 2020|Categories: Past Webinars|

Presenter: Carl Amilon (AstraZeneca) Date: June 10, 2020 Description: This webinar will give an overview of how incorporating quantitative PK/PD aspects of an oligonucleotide will help you designing more informative experiments and help in translating to a human. We have all struggled with questions around the ...

Go to Top